Important Safety Information | Prescribing Information | Medication Guide

Patient Support From TYMLOS

We are committed to helping you as you begin your journey with TYMLOS.

Since every journey is different, you have a choice to sign up for whatever support works best for you. There are two options, described below. You can either receive the TYMLOS Starter Kit, participate in the TYMLOS Clinical Educator Program, or do both!

TYMLOS Starter Kit - You’ll get a stylish travel case for your TYMLOS injection pen along with an injection tracker and other helpful information.

TYMLOS Clinical Educator Program - This program is staffed by trained medical professionals who are passionate about educating patients like you. The Clinical Educators will provide you with individualized virtual self-injection training through phone call or video call on your desktop or tablet device until you are confident with your TYMLOS injection to help you start and stay on your treatment. If you elect to participate in this program, you will be asked to provide your consent below.

To begin the registration process for either, or both of these options, first provide the information requested below. Required items are marked with an ( * ).


TYMLOS is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture.

†While supplies last. Quantities limited.

*Phone number must be 10 digits long without any spaces, hyphens or text

TYMLOS Clinical Educator Program Patient Consent:

I understand that the Clinical Educators are TYMLOS product experts who will give me guidance on how to use the TYMLOS injection pens. I understand that they do not take the place of my medical care team and that no medical advice will be provided to me during this program. I understand that if I need medical advice regarding the medication, I will contact my healthcare provider directly. I acknowledge that the program is paid for by Radius. Sessions may also include individuals from Radius who are not Clinical Educators but are acting in a capacity to observe and provide feedback on the educational program and will not be active participants in the program.

I authorize Radius Health, Inc., its agents, and third-party contractors or service providers for the Radius Patient Support Services, including vendors providing relevant patient education services related to the Program” (together, the “Alliance”), to disclose my Personal Health Information (PHI) about me as applicable, including, but not limited to, my medical diagnosis as applicable, including, but not limited to, my medical diagnosis, condition, treatment (including prescription information), financial information, demographic information, and contact information, as provided herein.

I authorize such disclosures so that Alliance may use and share my PHI for the following purposes:

  • to provide information, training, and education related to the use of TYMLOS;
  • internal use by Alliance, including education, business analytics, marketing studies, or for other commercial purposes to evaluate services and to improve future products and services;
  • communicating with me by mail, email, text message, telephone, or other means about the Program, my medical condition, products, treatment, and care management;
  • to contact me about my interest in promotions, services, and research studies, and to ask my opinion about such information and topics including market research and disease-related surveys;
  • to contact me about participating in a mentor program.

I understand that I do not have to enroll in the Program or receive the communications mentioned above and that I can still receive TYMLOS, as prescribed by my Healthcare Provider.

I may opt-out of individual support services or the program entirely at any time by clicking here.

I understand that I am entitled to request a copy of this Authorization over the time it is valid.

I certify that I am at least eighteen (18) years of age.

I also understand that the Program may be revised, changed, or terminated at any time without any prior notification.


Finally, please provide your consent as requested below, press submit, and then you are done!

I certify that my Healthcare Provider has provided me with a prescription or a sample for TYMLOS, and that I have received medical guidance regarding this treatment directly from my Healthcare Provider. I also understand and agree to Radius Health, Inc.’s terms. Additionally, I agree to receive information about TYMLOS, osteoporosis, and other information from Radius or its program providers. I understand that my information will be used as described here and in the Radius Health Privacy Policy.

You may opt-out of receiving marketing communications from Radius Health by clicking here.




What is the most important information I should know about TYMLOS?

TYMLOS may cause serious side effects including:
Possible bone cancer (osteosarcoma). During animal drug testing, TYMLOS caused some rats to develop a bone cancer called osteosarcoma. It is not known if people who take TYMLOS will have a higher chance of getting osteosarcoma.

IMPORTANT SAFETY INFORMATION AND INDICATIONS

What is the most important information I should know about TYMLOS?

TYMLOS may cause serious side effects including:

Possible bone cancer (osteosarcoma). During animal drug testing, TYMLOS caused some rats to develop a bone cancer called osteosarcoma. It is not known if people who take TYMLOS will have a higher chance of getting osteosarcoma.

  • Tell your healthcare provider right away if you have pain in your bones, pain in any areas of your body that does not go away, or any new or unusual lumps or swelling under your skin that is tender to touch.

Do not take TYMLOS:

  • if you had an allergic reaction to abaloparatide or any of the other ingredients in TYMLOS. The inactive ingredients in TYMLOS are phenol, sodium acetate trihydrate, acetic acid, and water for injection.

Before you take TYMLOS, tell your healthcare provider about all of your medical conditions, including if you:

  • have Paget’s disease of the bone or other bone disease.
  • have or have had any of the following: cancer in your bones; radiation therapy involving your bones; too much calcium in your blood; or an increase in your parathyroid hormone (hyperparathyroidism).
  • will have trouble injecting yourself with the TYMLOS pen and do not have someone who can help you.
  • are pregnant or plan to become pregnant, because TYMLOS is not for pregnant women, or if you are breastfeeding or plan to breastfeed. It is not known if TYMLOS passes into your breast milk; you should not take TYMLOS and breastfeed.

Tell your healthcare provider about all the medicines you take, including prescription and over-the- counter medicines, vitamins, and herbal supplements.

What are the possible side effects of TYMLOS?

TYMLOS can cause serious side effects including:

  • Decrease in blood pressure when you change positions. Some people may feel dizzy, have a faster heartbeat, or feel lightheaded soon after the TYMLOS injection is given. These symptoms generally go away within a few hours. Take your injection of TYMLOS in a place where you can sit or lie down right away if you get these symptoms. If your symptoms get worse or do not go away, stop taking TYMLOS and call your healthcare provider.
  • Increased blood calcium (hypercalcemia). TYMLOS can cause some people to have a higher blood calcium level than normal. Your healthcare provider may check your blood calcium before you start and during your treatment with TYMLOS. Tell your healthcare provider if you have nausea, vomiting, constipation, low energy, or muscle weakness. These may be signs there is too much calcium in your blood.
  • Increased urine calcium (hypercalciuria). TYMLOS can cause some people to have higher levels of calcium in their urine than normal. Increased calcium may also cause you to develop kidney stones (urolithiasis) in your kidneys, bladder, or urinary tract. Tell your healthcare provider right away if you get any symptoms of kidney stones which may include pain in your lower back or lower stomach area, pain when you urinate, or blood in your urine.

The most common side effects of TYMLOS in women with postmenopausal osteoporosis include:

  • dizziness, nausea, headache, fast heartbeat, feeling tired (fatigue), upper stomach pain, and spinning feeling (vertigo).

The most common side effects of TYMLOS in men with osteoporosis include:

  • redness at injection site, dizziness, joint pain, swelling at injection site, pain at injection site, bruising, abdominal bloating, diarrhea, nausea, abdominal pain, and bone pain.

These are not all the possible side effects of TYMLOS. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.


How should I use TYMLOS?

  • Read the complete Instructions for Use provided with your medicine.
  • If you take more TYMLOS than prescribed you may experience symptoms such as muscle weakness, low energy, headache, nausea, dizziness (especially when getting up after sitting for a while), and a faster heartbeat. Stop taking TYMLOS and call your healthcare provider right away.
  • You should not use TYMLOS for more than 2 years over your lifetime.

What is TYMLOS?

TYMLOS is a prescription medicine used to:

  • Treat osteoporosis in postmenopausal women who are at high risk for bone fracture, or who cannot use another osteoporosis treatment or other osteoporosis treatments did not work well. TYMLOS can decrease the chance of having a fracture of the spine and other bones in postmenopausal women with thinning and weakening bones (osteoporosis).
  • Increase bone density in men with osteoporosis who are at high risk for bone fracture, or who cannot use another osteoporosis treatment or other osteoporosis treatments did not work well.

It is not known if TYMLOS is safe and effective for children and young adults 18 years and younger. TYMLOS should not be used in children and young adults whose bones are still growing.


Please see full Prescribing Information, including Medication Guide at tymlospi.com